News Neuroscience

Women have a new weapon against postpartum depression, but it’s costly

The newly approved drug brexanolone simulates a natural steroid to alleviate symptoms

mother pushing stroller

RELIEF ON THE HORIZON  Roughly 1 in 9 women who give birth in the United States experience symptoms of postpartum depression. Now, a new drug aimed directly at treating the disorder offers new hope for finding relief.

globalmoments/Shutterstock

By Jeremy Rehm

- More than 2 years ago

Approval of the first and only treatment in the United States specifically targeting postpartum depression offers hope for millions of women each year who suffer from the debilitating mental health disorder after giving birth.